» Articles » PMID: 18490657

Identification and Characterization of Transmitted and Early Founder Virus Envelopes in Primary HIV-1 Infection

Abstract

The precise identification of the HIV-1 envelope glycoprotein (Env) responsible for productive clinical infection could be instrumental in elucidating the molecular basis of HIV-1 transmission and in designing effective vaccines. Here, we developed a mathematical model of random viral evolution and, together with phylogenetic tree construction, used it to analyze 3,449 complete env sequences derived by single genome amplification from 102 subjects with acute HIV-1 (clade B) infection. Viral env genes evolving from individual transmitted or founder viruses generally exhibited a Poisson distribution of mutations and star-like phylogeny, which coalesced to an inferred consensus sequence at or near the estimated time of virus transmission. Overall, 78 of 102 subjects had evidence of productive clinical infection by a single virus, and 24 others had evidence of productive clinical infection by a minimum of two to five viruses. Phenotypic analysis of transmitted or early founder Envs revealed a consistent pattern of CCR5 dependence, masking of coreceptor binding regions, and equivalent or modestly enhanced resistance to the fusion inhibitor T1249 and broadly neutralizing antibodies compared with Envs from chronically infected subjects. Low multiplicity infection and limited viral evolution preceding peak viremia suggest a finite window of potential vulnerability of HIV-1 to vaccine-elicited immune responses, although phenotypic properties of transmitted Envs pose a formidable defense.

Citing Articles

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge.

Chege G, Chapman R, Keyser A, Adams C, Benn K, van Diepen M Viruses. 2025; 17(2).

PMID: 40007032 PMC: 11861162. DOI: 10.3390/v17020277.


HIV-1 Rebound Virus Consists of a Small Number of Lineages That Entered the Reservoir Close to ART Initiation.

Tyers L, Moeser M, Ntuli J, Council O, Zhou S, Spielvogel E bioRxiv. 2025; .

PMID: 39975202 PMC: 11838395. DOI: 10.1101/2025.01.29.635391.


HIV-1 Vif global diversity and possible APOBEC-mediated response since 1980.

Lewitus E, Li Y, Rolland M Virus Evol. 2025; 11(1):veae108.

PMID: 39886100 PMC: 11781276. DOI: 10.1093/ve/veae108.


Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistance.

Cohen P, Lambson B, Mkhize N, Moodley C, Yssel A, Moyo-Gwete T J Virol. 2025; 99(2):e0173024.

PMID: 39817771 PMC: 11852940. DOI: 10.1128/jvi.01730-24.


It's all in the gut: the central role of the gut and microbiome in preventing disease progression in simian immunodeficiency viruses infected African nonhuman primates.

Raehtz K, Pandrea I, Apetrei C Curr Opin HIV AIDS. 2025; 20(2):124-132.

PMID: 39774258 PMC: 11802300. DOI: 10.1097/COH.0000000000000911.


References
1.
Ritola K, Pilcher C, Fiscus S, Hoffman N, Nelson J, Kitrinos K . Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1. J Virol. 2004; 78(20):11208-18. PMC: 521858. DOI: 10.1128/JVI.78.20.11208-11218.2004. View

2.
J Wawer M, H Gray R, Sewankambo N, Serwadda D, Li X, Laeyendecker O . Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005; 191(9):1403-9. DOI: 10.1086/429411. View

3.
Ho D, Neumann A, Perelson A, Chen W, Leonard J, Markowitz M . Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995; 373(6510):123-6. DOI: 10.1038/373123a0. View

4.
Frost S, Wrin T, Smith D, Kosakovsky Pond S, Liu Y, Paxinos E . Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci U S A. 2005; 102(51):18514-9. PMC: 1310509. DOI: 10.1073/pnas.0504658102. View

5.
Shattock R, Moore J . Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol. 2004; 1(1):25-34. DOI: 10.1038/nrmicro729. View